Gainers
- Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.
- Oncternal Therapeutics, Inc. (NASDAQ: ONCT) jumped 88.1% to settle at $1.54. Oncternal Therapeutics presented updated interim data for zilovertamab in combination with ibrutinib at ASCO 2022.
- SIGA Technologies, Inc. (NASDAQ: SIGA) climbed 41.9% to close at $13.68. European Union has agreed to buy Bavarian Nordic's Imvanex, Tecoviriat from Siga in the US.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) rose 39.3% to close at $2.87 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and an $8 price target.
- Imperial Petroleum Inc. (NASDAQ: IMPP) gained 38.4% to close at $0.5480. Imperial Petroleum announced agreement to acquire two Suezmax tankers for $46.8 million.
- JE Cleantech Holdings Limited (NASDAQ: JCSE) surged 34.8% to close at $14.99.
- Merus N.V. (NASDAQ: MRUS) jumped 32.6% to close at $18.53. Merus announced the publication of abstract of Zenocutuzumab in NRG1-fusion (NRG1+) cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
- Farfetch Limited (NASDAQ: FTCH) jumped 26.7% to close at $9.73 following Q1 results.
- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) surged 25.7% to close at $20.88.
- Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 25.5% to settle at $0.7530.
- Icosavax, Inc. (NASDAQ: ICVX) gained 25.4% to close at $10.23. Icosavax recently posted a Q1 loss of $0.60 per share.
- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) jumped 25.1% to close at $10.77 after the company reported better-than-expected Q1 results.
- MoonLake Immunotherapeutics (NASDAQ: MLTX) gained 24.6% to close at $6.38. MoonLake Immunotherapeutics recently dosed first patient in the Phase 2 clinical trial evaluating sonelokimab, for patients with moderate-to-severe hidradenitis suppurativa (HS).
- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) gained 24.4% to close at $0.75.
- MiNK Therapeutics, Inc. (NASDAQ: INKT) gained 22.8% to close at $1.67. MiNK Therapeutics recently posted a Q1 loss of $0.23 per share.
- SoundHound AI, Inc. (NASDAQ: SOUN) surged 21.3% to close at $7.91.
- Applied Blockchain, Inc. (NASDAQ: APLD) gained 21.1% to settle at $4.60.
- 111, Inc. (NASDAQ: YI) gained 20.8% to close at $1.92.
- Ontrak, Inc. (NASDAQ: OTRK) gained 20.6% to close at $1.93.
- Arcellx, Inc. (NASDAQ: ACLX) rose 20.6% to close at $11.55.
- Enochian Biosciences, Inc. (NASDAQ: ENOB) jumped 20.5% to close at $5.35. The co-founder of Enochian Biosciences was arrested Wednesday following a two-year investigation into a man who was kidnapped and found dead in January 2018.
- Super Group (SGHC) Limited (NYSE: SGHC) gained 19.7% to settle at $7.22.
- Rent the Runway, Inc. (NASDAQ: RENT) jumped 19.6% to close at $4.40.
- Vivos Therapeutics, Inc. (NASDAQ: VVOS) rose 19.1% to settle at $1.87. Vivos Therapeutics recently posted a Q1 loss of $0.26 per share.
- Zymergen Inc. (NASDAQ: ZY) jumped 19% to close at $1.38.
- Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) gained 18.8% to close at $1.1350.
- Carver Bancorp, Inc. (NASDAQ: CARV) surged 18.5% to close at $11.58.
- Archer Aviation Inc. (NYSE: ACHR) jumped 18.5% to settle at $4.10.
- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) surged 18.4% to close at $3.86.
- AMC Entertainment Holdings, Inc. (NYSE: AMC) gained 18% to settle at $14.43.
- Express, Inc. (NYSE: EXPR) surged 17.7% to close at $3.00. Express recently reported better-than-expected Q1 sales results and raised its FY22 guidance.
- Amyris, Inc. (NASDAQ: AMRS) jumped 17.6% to close at $2.67.
- Novavax, Inc. (NASDAQ: NVAX) gained 17.5% to settle at $55.29. B of A Securities recently initiated coverage on the stock with an Underperform rating.
- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) climbed 17.1% to close at $5.88 after gaining over 7% on Thursday. Concert Pharmaceuticals recently announced topline results from its Phase 3 THRIVE-AA1 trial of CTP-543 in adult patients with moderate to severe alopecia areata (AA).
- Renalytix Plc (NASDAQ: RNLX) gained 17% to close at $4.19.
- PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) shares gained 16.1% to close at $15.33. PMV Pharmaceuticals announced initial PC14586 Phase 1 clinical data to be presented at the 2022 American Society of Clinical Oncology Annual Meeting June 7.
- Houston American Energy Corp. (NASDAQ: HUSA) gained 16.1% to close at $3.76.
- Karooooo Ltd. (NASDAQ: KARO) rose 14.9% to close at $28.95.
- Opendoor (NASDAQ:OPEN) Technologies Inc. (NASDAQ: OPEN) gained 14.8% to close at $7.49.
- Adicet Bio, Inc. (NASDAQ: ACET) rose 14.5% to close at $11.75 after reporting positive clinical update from ADI-001 Phase 1 Trial in relapsed/refractory Non-Hodgkin’s Lymphoma.
- Omega Therapeutics, Inc. (NASDAQ: OMGA) rose 14% to settle at $2.53.
- Dell Technologies Inc. (NYSE: DELL) climbed 12.9% to close at $49.58 after the company reported better-than-expected Q1 results.
- Ulta Beauty, Inc. (NASDAQ: NASDAQ:ULTA) gained 12.5% to close at $425.08 after the company reported better-than-expected Q1 results and raised FY22 net sales guidance.
- Solo Brands, Inc. (NYSE: DTC) shares gained 8.3% to close at $4.94. Solo Brands recently reported worse-than-expected Q1 sales results.
Losers
- Performance Shipping Inc. (NASDAQ: PSHG) shares dipped 63.6% to close at $0.6632 on Friday after the company announced the pricing of an underwritten public offering of 7,620,000 units at $1.05 per unit. Each unit consists of one common share and one Class A warrant to purchase one common share.
- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares dipped 53.6% to close at $7.02 after the company reported results from its C-144-01 clinical study in patients with advanced melanoma. Piper Sandler and Chardan Capital lowered their price targets on the stock.
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) fell 40.5% to close at $18.36 after the company announced initial clinical data from the Phase 1/2 study evaluating nirogacestat.
- Aurora Cannabis Inc. (NASDAQ: ACB) dropped 38.5% to close at $1.68 after the company announced upsized bought deal financing of $150 million.
- MSP Recovery, Inc. (NASDAQ: MSPR) dropped 32.3% to close at $1.74.
- Mirati Therapeutics, Inc. (NASDAQ: MRTX) fell 31.9% to close at $39.81. Mirati Therapeutics reported positive results from the registration-enabling Phase 2 cohort of the KRYSTAL-1 study evaluating adagrasib 600 mg BID in patients with non-small cell lung cancer (NSCLC) harboring the KRASG12C mutation who have received at least one prior systemic therapy.
- CASI Pharmaceuticals, Inc. (NASDAQ: CASI) dipped 28.9% to settle at $0.37. Casi Pharmaceuticals announced a 1-for-10 reverse stock split effective June 1.
- I-Mab (NASDAQ: IMAB) fell 26.9% to close at $8.27 as the company reported preliminary data of its ongoing Phase 2 clinical trial (NCT04322006) with uliledlimab, a differentiated CD73 antibody, and its global clinical development plan.
- Tempest Therapeutics, Inc. (NASDAQ: TPST) dipped 26.7% to close at $2.83.
- Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) fell 26.3% to close at $2.50.
- Mesa Royalty Trust (NYSE: MTR) dipped 26.3% to close at $17.50.
- Instil Bio, Inc. (NASDAQ: TIL) dropped 24.3% to close at $6.00 as the company reported the IND clearance of first CoStAR-TIL program, ITIL-306, designed to enhance activity in the tumor microenvironment.
- Quanergy Systems, Inc. (NYSE: QNGY) dipped 22.3% to settle at $0.5441.
- Bright Green Corporation (NASDAQ: BGXX) fell 21.7% to close at $6.18.
- Bon Natural Life Limited (NASDAQ: BON) fell 20.8% to settle at $3.77.
- The Very Good Food Company Inc. (NASDAQ: VGFC) dipped 18.7% to close at $0.2582. The Very Good Food Company recently announced it increased retail distribution across Canada with Loblaw Companies.
- UTStarcom Holdings Corp. (NASDAQ: UTSI) fell 18.3% to close at $0.6128.
- ToughBuilt Industries, Inc. (NASDAQ: TBLT) dropped 16.7% to close at $5.00.
- Genocea Biosciences, Inc. (NASDAQ: GNCA) declined 16.3% to settle at $0.0620. Genocea Biosciences recently announced it is winding down operations and delisting from NASDAQ.
- Guardion Health Sciences, Inc. (NASDAQ: GHSI) dropped 15.3% to close at $0.1727. Guardion Health Sciences recently posted a Q1 loss of $0.07 per share.
- Creatd, Inc. (NASDAQ: CRTD) fell 14.1% to close at $1.10.
- SciSparc Ltd. (NASDAQ: SPRC) fell 13.8% to close at $2.87. SciSparc announced pricing of $10 million private placement priced at-the-market.
- Big Lots, Inc. (NYSE: NYSE:BIG) declined 12.1% to close at $26.94 after the company reported Q1 EPS results down from last year and worse-than-expected sales results.
- TC Biopharm (Holdings) Plc (NASDAQ: TCBP) dropped 11.7% to close at $0.7681.
- Citi Trends, Inc. (NASDAQ: CTRN) dropped 11.4% to close at $29.76. Citi Trends recently reported better-than-expected Q1 adjusted EPS and sales results.
- Workday, Inc. (NASDAQ: WDAY) fell 5.6% to close at $158.79 after the company reported worse-than-expected Q1 EPS results.
Read at Benzinga